kapynFunding & M&A

Why biological data matters more in AI drug discovery

GSK partners with Relation Therapeutics in a $110 million AI drug discovery deal. Relation will generate large-scale datasets measuring cellular responses to genetic changes and drugs to train machine learning models. This partnership highlights the critical role proprietary biological data plays in advancing pharmaceutical machine learning applications.

AI News·Aug 3, 2026

Opening Kapyn…